journal article·2009-02-10

Controlled Drug Release from Ureasil−Polyether Hybrid Materials

C. V. Santilli, L. A. Chiavacci, L. Lopes, S. H. Pulcinelli, A. G. Oliveira

Chemistry of Materials· Volume 21· Issue 3
Publisher page

Abstract

Flexible, transparent, and insoluble urea-cross-linked polyether−siloxane hybrids presenting a tunable drug delivery pattern were prepared using the sol−gel method from PEO (poly(ethylene oxide)) and PPO (poly(propylene oxide)) functionalized at both chain ends with triethoxysilane. Different polyether chain lengths were used to control the urea/siloxane (named ureasil) node density, flexibility, and swellability of the hybrid network. We herein demonstrate that the drug release from swellable hydrophilic ureasil−PEO hybrids can be sustained for some days, whereas that from the unswellable ureasil−PPO hybrids can be sustained for some weeks. This outstanding feature conjugated with the biomedically safe formulation of the ureasil cross-linked polyether-siloxane hybrid widens their scope of application to include the domain of soft and implantable drug delivery devices.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Polymer Synthesis and Characterization · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Química, Universidade Estadual Paulista, 14800-900 Araraquara, São Paulo, Brazil, and Faculdade Ciências Farmacêuticas, Universidade Estadual Paulista, 14801-902 Araraquara, São Paulo, Brazil

References (18)

Show source-provided references
1. Belting M. · Adv. Drug Delivery Rev. · 2005 · 57 · 50510.1016/j.addr.2004.10.004 ↗
2. Nori A. · Adv. Drug Delivery Rev. · 2005 · 57 · 60910.1016/j.addr.2004.10.006 ↗
3. Uhrich K. E. · Chem. Rev. · 1999 · 99 · 318110.1021/cr940351u ↗
4. Orive G. · Cancer Ther. · 2005 · 3 · 131
5. Peppas N. A. · Adv. Mater. · 2006 · 18 · 134510.1002/adma.200501612 ↗
6. Kim S. W. · Pharm. Res. · 1992 · 9 · 28310.1023/A:1015887213431 ↗
7. Jeong B. · Nature · 1997 · 388 · 86010.1038/42218 ↗
8. Kabanov A. V. · J. Controlled Release · 2002 · 82 · 18910.1016/S0168-3659(02)00009-3 ↗
9. Bromberg L. · Int. J. Pharm. · 2004 · 282 · 4510.1016/j.ijpharm.2004.05.030 ↗
10. Haraguchi K. · Adv. Mater. · 2002 · 14 · 112010.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9 ↗
11. Shekunov B. Y. · J. Pharm. Sci. · 2007 · 96 · 132010.1002/jps.20950 ↗
12. Abd El-Rehim H. A. · Polym. Adv. Technol. · 2004 · 15 · 54410.1002/pat.501 ↗
13. Llina’s A. · J. Med. Chem. · 2007 · 50 · 97910.1021/jm0612970 ↗
14. Dahmouche K. · J. Phys. Chem. B · 1999 · 103 · 493710.1021/jp984605h ↗
15. Chaker J. A. · J. Mater. Chem. · 2007 · 17 · 74410.1039/B612587E ↗
16. Gonçalves M. C. · J. Phys. Chem. B · 2005 · 109 · 2009310.1021/jp052097n ↗
17. Chiavacci L. A. · J. Appl. Crystallogr. · 2003 · 36 · 40510.1107/S0021889803000517 ↗
18. Molina C. · Chem. Mater. · 2001 · 13 · 281810.1021/cm0012320 ↗